Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2025-06-03 00:00:00 ET · period of report 2025-05-30 · accession 0000950170-25-081036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-06-03 | 2025-05-30 | DLB | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | S - Sale | $74.97 | -350 | 62.4K | -0.6% | -$26.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-30 | S | D | 350 | $74.97 | 62,397 | D | — | — | (F2) Shares sold in the reported transaction consist of 350 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. (F1) Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |